Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ

PloS One
Fenping ZhengHong Li

Abstract

Liver X receptors (LXRs) have been recognized as a promising therapeutic target for atherosclerosis; however, their role in insulin sensitivity is controversial. Adiponectin plays a unique role in maintaining insulin sensitivity. Currently, no systematic experiments elucidating the role of LXR activation in insulin function based on adiponectin signaling have been reported. Here, we investigated the role of LXR activation in insulin resistance based on adiponectin signaling, and possible mechanisms. C57BL/6 mice maintained on a regular chow received the LXR agonist, T0901317 (30 mg/kg.d) for 3 weeks by intraperitoneal injection, and differentiated 3T3-L1 adipocytes were treated with T0901317 or GW3965. T0901317 treatment induced significant insulin resistance in C57BL/6 mice. It decreased adiponectin gene transcription in epididymal fat, as well as serum adiponectin levels. Activity of AMPK, a key mediator of adiponectin signaling, was also decreased, resulting in decreased Glut-4 membrane translocation in epididymal fat. In contrast, adiponectin activity was not changed in the liver of T0901317 treated mice. In vitro, both T0901317 and GW3965 decreased adiponectin expression in adipocytes in a dose-dependent manner, an effect ...Continue Reading

References

May 7, 2015·Biomolecular Concepts·Marion Korach-André, Jan-Åke Gustafsson
Jun 6, 2018·International Journal of Molecular Sciences·Véronique Ferret-SenaArmando Sena
Dec 4, 2016·Journal of Endocrinological Investigation·X Z ZhangK Murao

Citations

Nov 23, 2000·Genes & Development·J R SchultzB Shan
Jan 10, 2002·Genes & Development·Evan D RosenBruce M Spiegelman
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sean B JosephPeter Tontonoz
Nov 5, 2002·The Journal of Biological Chemistry·Guoqing CaoGarret J Etgen
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bryan A LaffittePeter Tontonoz
Sep 13, 2003·The Journal of Biological Chemistry·Knut Tomas DalenHilde I Nebb
Mar 19, 2004·Diabetes & Metabolism·M Guerre-Millo
Feb 16, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M BouskilaP E Scherer
May 18, 2005·Endocrine Reviews·Takashi Kadowaki, Toshimasa Yamauchi
Jun 9, 2005·American Journal of Physiology. Endocrinology and Metabolism·Aldo GrefhorstFolkert Kuipers
Nov 22, 2005·Biochimie·Christian DarimontKatherine Macé
Apr 6, 2006·Clinical Endocrinology·Tiziana RontiElmo Mannarino
Aug 25, 2007·Molecular Endocrinology·S Renee CommerfordEnrique Saez
Sep 3, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jieli ChenMichael Chopp
Oct 30, 2010·The Journal of Biological Chemistry·B M StensonJ Laurencikiene
Dec 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marion Korach-AndréJan-Åke Gustafsson
Apr 16, 2011·Circulation Research·Seung-Soon Im, Timothy F Osborne
Apr 26, 2011·Life Sciences·Akihiro KudohTsuyoshi Watanabe
May 5, 2011·American Journal of Physiology. Endocrinology and Metabolism·Qian GeSonia M Brichard
Jan 29, 2013·Cell Metabolism·Toshimasa Yamauchi, Takashi Kadowaki
Jun 15, 2013·Diabetologia·A M L PetterssonJ Laurencikiene
Jul 31, 2013·The Biochemical Journal·Robert Stöhr, Massimo Federici
Oct 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Fenfen WangMitchell A Lazar
Nov 22, 2013·Journal of Lipid Research·Lea DibSheila Collins

Related Concepts

Metabolic Process, Cellular
Real-Time Polymerase Chain Reaction
Insulin Sensitivity
PPARA wt Allele
Exertion
Fat Pad
Adiponectin
Transfection
Tissue Membrane
HEK293 Cells

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.